The Effectiveness of Tiptajo Cream for Treatment of Mild to Moderate Dermatitis

Phase 2

• Conditions: Dermatitis; Dermatitis, Eczema

• Registration Number: TCTR20220313002
• Lead Sponsor: Agricutural Research Development Agency (ARDA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-13
• Study Completion: 2022-12-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 304

Inclusion Criteria

1.Male or female with age from 18 to 60 years
2.Participants who diagnosed mild to moderate dermatitis
3.Participants who willing to participate the study

Exclusion Criteria

1.Pregnant or breastfeeding woman.
2.Participants with elevated liver enzymes more than two times of normal upper limit.
3.Participants with chronic kidney disease or acute kidney injury.
4.Participants who experienced allergy to any ingredient of Tiptajo cream or topical steroids.
5.Participants with severe dermatitis.
6.Participants with other underlying diseases or medical problems that would interfere with the study.
7.Participants who undergo other treatments for dermatitis (e.g., laser or other topical medications)
8.Participants with other skin diseases that required treatment with other medications (e.g., fungal infections, psoriasis, acne).

Study & Design

• Study Type: Interventional
• Study Design: Not specified